Purchase Order N6311624P0548
Award Date
8/27/24
Potential Completion Date
4/8/25
Potential Value
$41K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract, valued at $80,858.46, is for the delivery of various Illumina sequencing systems, reagents, and consumables to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This award is made under an...
This is a $99,996.96 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract is for the delivery of Illumina's RNA Prep with Enrichment kits, MiSeq reagent kits, respiratory virus oligo panels, and DNA/RNA universal dual (UD) indexes to support genomic sequencing and analysis requirements at the Naval Health Research Center in San Diego, California....
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for $97,678.20. The award provides Illumina's RNA sequencing products and reagents to support the Naval Health Research Center's (NHRC) laboratory work characterizing biological threats. The contract has a period of performance through December 1, 2021. This award is not associated with a set-aside program. Illumina has previously...
This is a sole-source federal contract award from the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $76,243.05 firm fixed-price purchase order is for Illumina's RNA Prep with Enrichment kits, IDT for Illumina DNA/RNA UD Indexes, Respiratory Virus Oligo Panel v2, and MiSeq Reagent Kits to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research...
This is a $99,835.14 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Illumina, Inc. The contract is for the provision of Illumina RNA sequencing products and reagents, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, sample preparation kits, sequencing chips, and related consumables and support services. These items will support genomic sequencing and bioinformatics analysis for research and...
This is a firm fixed-price purchase order awarded by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $89,348 contract is for Illumina's RNA Prep with Enrichment, DNA/RNA Universal Dual Indexes, Respiratory Virus Oligo Panel, and MiSeq reagent kits to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This award is part of an...
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
This is a $80,778.39 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for CAT# MS-102-3003 MISEQ sequencing systems and associated items. The contract has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing various sequencing platforms and consumables to support genomics research and diagnostic...
This is a delivery order awarded by the Department of the Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $67,493.84 fixed-price contract is for the provision of medical laboratory supplies, specifically reagents and controls for Illumina's MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms. These instruments are used by the Naval Medical Research Center's Biological Defense Research Directorate to characterize...
This $13,447.16 firm fixed price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract is to provide a NextSeq DNA library preparation kit and related consumables to support nucleic acid sequencing capabilities at the Naval Health Research Center's Biological Defense Research Directorate in San Diego, California. The award is not associated with a larger...